Finance

Beta
Lists
0809:HKG
Global Bio-chem Technology Group Co Ltd
HK$0.060
0.00%
(0.00) 1D
Jun 5, 4:09:10 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0809...
Open
HK$0.06
High
HK$0.06
Low
HK$0.06
Mkt. cap
1.01B
Avg. vol.
5.93M
Volume
4.52M
P/E ratio
10.79
52-wk high
HK$0.12
52-wk low
HK$0.06
EPS
HK$0.01
Shares outstanding
6.40B
No. of employees
2K
Open
HK$0.06
High
HK$0.06
Low
HK$0.06
Mkt. cap
1.01B
Avg. vol.
5.93M
Volume
4.52M
P/E ratio
10.79
52-wk high
HK$0.12
52-wk low
HK$0.06
EPS
HK$0.01
Shares outstanding
6.40B
No. of employees
2K
News stories
From sources across the web
Profile
Global Bio-Chem Technology Group, also known as simply Global Bio-Chem, is a Chinese biotechnology company based in Hong Kong. The company is owned by Changchun Dacheng Industry Group. Wikipedia
About Global Bio-chem Technology Group Co Ltd
CEO-
Employees1.89K
Founded1994
Headquarters-
SectorFood
Websiteglobalbiochem.com
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in HKD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
592.99M
592.99M
546.27M
546.27M
Cost of goods sold
512.39M
512.39M
528.65M
528.65M
Cost of revenue
512.39M
512.39M
528.65M
528.65M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
67.46M
67.46M
85.37M
85.37M
Operating expense
67.46M
67.46M
85.37M
85.37M
Total operating expenses
579.85M
579.85M
614.02M
614.02M
Operating income
13.14M
13.14M
-67.75M
-67.75M
Other non operating income
1.93M
1.93M
-45.51M
-45.51M
EBT including unusual items
-77.37M
-77.37M
155.57M
155.57M
EBT excluding unusual items
-78.44M
-78.44M
-172.29M
-172.29M
Income tax expense
-
-
55.00K
55.00K
Effective tax rate
-
-
0.04%
0.04%
Other operating expenses
-
-
-
-
Net income
-77.37M
-77.37M
155.52M
155.52M
Net profit margin
-13.05%
-13.05%
28.47%
28.47%
Earnings per share
-
-
-
-
Interest and investment income
1.00K
1.00K
3.00K
3.00K
Interest expense
-93.51M
-93.51M
-60.54M
-60.54M
Net interest expenses
-93.51M
-93.51M
-60.54M
-60.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
36.61M
36.61M
-37.55M
-37.55M
Gain or loss from assets sale
-
-
-7.10M
-7.10M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer